The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9303033, E46, Table 51A, Compound 4 ID: ALA3986376
PubChem CID: 136483859
Max Phase: Preclinical
Molecular Formula: C23H21N9O2
Molecular Weight: 455.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(Nc2ccc(-n3cccn3)cc2)nc2c(/C=C3\NC(=O)NC3=O)cnn2c1NC1CC1
Standard InChI: InChI=1S/C23H21N9O2/c1-13-19(26-15-5-7-17(8-6-15)31-10-2-9-24-31)29-21-14(11-18-22(33)30-23(34)28-18)12-25-32(21)20(13)27-16-3-4-16/h2,5-12,16,27H,3-4H2,1H3,(H,26,29)(H2,28,30,33,34)/b18-11-
Standard InChI Key: YCIVLENCEVEADC-WQRHYEAKSA-N
Molfile:
RDKit 2D
34 39 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5972 1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8915 3.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8863 5.2585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5847 6.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2883 5.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2934 3.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5795 7.5047 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7887 8.3707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3179 9.7949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8179 9.7874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3616 8.3585 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7248 1.2135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1905 2.6376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6589 2.9478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7489 1.9359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.0504 2.6816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.1450 2.1899 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.7434 4.1499 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2521 4.3116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6494 5.3492 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6065 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7248 -1.2135 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0031 -3.0008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3039 -3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9792 -5.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7246 -3.6986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 11 1 0
3 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 1 0
22 23 2 0
22 24 1 0
24 25 1 0
25 20 1 0
25 26 2 0
18 27 1 0
27 28 2 0
28 29 1 0
29 17 1 0
29 30 1 0
30 2 2 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 455.48Molecular Weight (Monoisotopic): 455.1818AlogP: 2.72#Rotatable Bonds: 6Polar Surface Area: 130.27Molecular Species: NEUTRALHBA: 9HBD: 4#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.24CX Basic pKa: 2.94CX LogP: 2.02CX LogD: 1.64Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.26Np Likeness Score: -1.68
References 1. (2016) Pyrazolopyrimidines and related heterocycles as CK2 inhibitors,